The pathogenesis of AD is also believed to be closely related to the microbiome; metabolic compounds derived from the microbiome have been linked to triggering the NLRP3 inflammasome pathway, amyloid-β accumulation, and phosphorylated tau/Aβ42 AD markers [187, 188]. This evidence concerns the gene MAPT and Alzheimer disease.